IRCT20171105037262N3
Completed
Phase 3
Comparison of Ozone Therapy and Routine Medical Treatment Effect on Disease Severity and Serum Level Changes of IL-33 in Patients with Multiple Sclerosis (MS)
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Multiple sclerosis.
- Sponsor
- Kashan University of Medical Sciences
- Enrollment
- 66
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Having Multiple Sclerosis
- •EDSS\=0\-4\.5
Exclusion Criteria
- •Unwillingness to continue cooperation
- •Any local or systemic inflammation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Ozone therapy and routine medical treatment efficacy on serum level changes of TNF-a and CRP as well as neurological improvementIschemic stroke.Transient cerebral ischemic attacks and related syndromesI63.9IRCT20200202046342N1Kashan University of Medical Sciences72
Recruiting
Not Applicable
Efficacy of Ozone Therapy on Allergic RhinitisIRCT20171105037262N2Kashan University of Medical Sciences40
Not yet recruiting
Phase 2
Comparison of the effectiveness of Ozone therapy with conventional therapy in the improvement of visual pathways function in diabetic patientsIRCT20191125045492N1Bagheiat-allah University of Medical Sciences60
Recruiting
Phase 2
Effect of Ozone therapy in treatment of COVID-19IRCT20191125045492N2Bagheiat-allah University of Medical Sciences80
Recruiting
Phase 2
Treatment modalities for TMJ disordersHealth Condition 1: M266- Temporomandibular joint disordersHealth Condition 2: M266- Temporomandibular joint disordersCTRI/2024/02/062579Satyendra Pratap Singh